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Abstract: 
Bacillithiol is an important compound involved in intracellular redox homeostasis and 
fosfomycin resistance mechanisms of some Gram-positive bacterial pathogens. Cellular 
regeneration of active bacillithiol (BSH) from a disulfide (BSSB) or mixed disulfide state (BSS-
Protein) involves the bacilliredoxin enzymes BrxA/B. An X-ray crystallographic structure of apo 
BrxA from Bacillus subtilis has been previously characterized, but no BrxB or BSSB-bound Brx 
structure currently exists. Here we present an X-ray crystallographic structure of BrxA from the 
pathogen Staphylococcus aureus with a bacillithiol disulfide (BSSB) bound in the active site. 
Elucidation of this structure will help researchers to understand how BSSB binds in 
bacilliredoxins, and provide insight into the Brx catalytic mechanism. Functional activity of 
YpdA, another enzyme involved in BSH regeneration, is also investigated.  
Introduction: 
Low molecular weight (LMW) thiols help to maintain intracellular redox homeostasis 
and provide protection from oxidative and electrophilic stress, such as from reactive oxygen 
species (ROS) (Helmann 2011, Zuber 2009). Reactive oxygen and reactive chlorine species are 
produced during host immune responses to damage invading pathogens (Linzner et al. 2019). 
LMW thiols can form S-conjugates with these toxic compounds allowing for their neutralization 
or removal. Gram-positive firmicutes including the pathogens Staphylococcus aureus and 
Bacillus anthracis produce the LMW bacillithiol (BSH) in high concentration, in contrast to 
glutathione, which is widespread among Gram-negative bacteria and eukaryotes (Mikheyeva 
2019). BSH can also act as a cofactor of enzymes such as FosB, which requires BSH to 
participate in deactivation of the antibiotic fosfomycin (Roberts et al. 2013). Target selectivity 
and BSH-dependent fosfomycin resistance makes BSH-associated enzymes a potential focus for 
inhibitory drug design, in which treatment would be applied in conjunction with fosfomycin. 
Disruption of the BSH pathway may also increase a pathogen’s vulnerability to environmental 
stresses and/or decrease resistance to the anti-TB drug rifamycin (Newton, Fahey and Rawat 
2012).  
The oxidation state of bacillithiol can alternate 
between a free thiol, a BSSB disulfide, or a BSS-
protein mixed disulfide in response to enzymatic 
catalysis or cellular conditions (Scheme 1). When 
Staphylococcus and Bacillus species are introduced 
to oxidative stress, BSH can be attached to protein 
thiol groups to protect them (Linzner et al. 2019, Mikheyeva 2019). Currently unknown enzymes 
perform a transferase reaction with BSH to form a BSS-protein disulfide, ensuring protection of 
the protein from oxidative damage. This protein must be subsequently debacillithiolated to 
further the BSH regeneration pathway and reestablish catalytic activity. It has been proposed that 
the bacilliredoxin enzymes BrxA and BrxB carry out this BSH transferase reaction, resulting in a 
BSS-Brx mixed disulfide and/or BSSB disulfide (Loi, Rossius and Antelmann 2015, Posada et 
Scheme 1- Brx-mediated debacillithiolation  
al. 2014). BSH regeneration is continued by other enzymes, including NADPH-dependent YpdA 
which is proposed to function as a bacillithiol disulfide reductase on BSS-Brx or BSSB to 
produce the free thiol (Mikheyeva 2019). Further investigation is needed to determine the role of 
YpdA in the BSH pathway.  
The X-ray crystallographic structure of apo BrxA from B. subtilis has been previously 
characterized (Figure 1), but no structure of a bacillithiol-bound Brx exists. The available BrxA 
structure displays an unusual CXC catalytic 
motif in contrast to the CXXC motif common 
among other thioredoxins. The CXC residues 
are key to the disulfide-exchange reactions 
characteristic of bacilliredoxins, but it is 
currently unknown which cysteine participates 
in the mixed disulfide with bacillithiol 
(Derewenda et al. 2009). Structural 
characterization of the Brx enzymes from S. 
aureus and B. subtilis under oxidative conditions is necessary to understand how and where 
bacillithiol binding occurs, as well as the mechanism of Brx activity. Here we describe the 1.4 Å 
X-ray crystallographic structure of BrxA from S. aureus with a bacillithiol disulfide bound in the 
active site.        
Materials and Methods 
Expression and purification 
Figure 1: Apo BrxA structure with CXC 
cysteines labeled 
Transformation of chemically competent E. coli BL-21(DE3) cells was accomplished 
using a pET28 expression vector encoding for an N-terminal hexahistidine tag and the 
bacilliredoxin gene. Transformed cells were plated on LB media containing 25 µg/mL 
kanamycin to allow for selection, and subsequently grown in liquid media until reaching an 
optical density of 0.97 for BrxA from S. aureus, 1.004 from B. subtilis, and 0.845, 0.66, for BrxB 
from B. subtilis. Bacilliredoxin production was induced by the addition of IPTG to a final 
concentration of 0.5 mM and the cultures agitated by shaking at 200 rpm in 16 °C for  ̴18-24 
hours. Cells were harvested via centrifugation, stored in -20 °C, resuspended in a buffered 
solution, lysed enzymatically and sonicated to produce a crude lysate. Bacilliredoxin purification 
was accomplished through nickel affinity chromatography, subsequent rTEV cleavage, and 
dialysis against 20 mM HEPES (pH 7.5) and 50 mM NaCl. Enzyme purity was assessed via 
SDS-PAGE analysis.  
Crystallization, data collection, and processing   
Bacilliredoxin crystallization trials were prepared using the hanging drop method of 
vapor diffusion. Crystallization was attempted with BrxA from B. subtilis in apo state and 
supplemented with 1 mM BSSB, and in BrxA from S. aureus in apo state and supplemented with 
either 1 mM BSSB, cysteine, N-acetylglucosamine (GlcNac), tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP), or dithiothreitol (DTT). X-ray diffraction experiments were performed 
via the Life Sciences Collaborative Access Team at Argonne National Laboratory. A data set 
was collected from suitable BrxA S. aureus crystals grown in a 0.2 M Ammonium phosphate 
monobasic, 20% w/v Polyethylene glycol 3,350 well solution. The data were processed with 
autoPROC (Vonrhein et al. 2011). The structure of BrxA was solved via molecular replacement 
with Phaser using BrxA from B. subtilis as the search probe (McCoy et al. 2007). The model was 
built in Coot (Emsley et al. 2010) and refined in Refmac (Murshudov et al. 2011). All figures 
were generated in PyMOL (PyMOL).  
Initial kinetics assay of YpdA  
Analysis of YpdA kinetic activity was measured using a Cary UV-Vis spectrophotometer 
at an absorbance of 340 nm, and a 50 mM HEPES (pH 8.0) 50 mM NaCl buffered solution 
containing either 180 µM NADPH, 12.5 µM FADH2, 40 µM BSSB with varied YpdA 
concentration, or, 12.5 µM YpdA, 180 µM NADPH, 12.5 µM FADH2, with varied BSSB 
concentration.  
Results and Discussion 
Expression and purification of BrxA and BrxB 
Analysis via SDS-PAGE indicated significant impurities in the expression of both BrxA 
and BrxB obtained from B. subtilis (Figures 2, 3, 4). The purity of BrxA S. aureus was assessed 
(Figure 5), and protein fractions numbered 12-25 were deemed pure, pooled, and stored.      
                                                                                             
 
 
Figure 2- SDS PAGE Gel of impure BrxA Bs 
from transformed BL-21 cells: Lane 1 includes 
a protein ladder. Lane 2 the crude lysate and 
lane 3 the clarified lysate.  
Figure 2- SDS PAGE analysis of impure BrxA 
Bs from transformed BL-21 cells: Lane 1 and 9 
include a protein ladder. Lane 2 the crude lysate 
and lane 3 the clarified lysate. Lane 4 the rTEV 
digest including rTEV, lane 5 without rTEV. Lane 
6 is empty. Lane 7 and 8 include 20µL and 5 µL of 
the purified enzyme.  
Figure 3- SDS PAGE analysis of impure BrxB 
Bs from transformed BL-21 cells: Lane 1 and 9 
include a protein ladder. Lane 2 the crude lysate 
and lane 3 the clarified lysate. Lane 4 rTEV digest. 
Lanes 5 and 7 are empty. Lanes 6 and 8 include 
20µL and 5µL of the purified enzyme.  
1  2  3 4  5 6  7 8  9  1  2  3 4 5  6 7  8 9  
                                                                             
 
YpdA Kinetics: 
Preliminary results of YpdA kinetics display a linear slope in absorbance over time, 
indicating enzymatic activity when 
accounting for background oxidation of 
NADPH (Figure 6). A somewhat linear 
relationship in initial velocity was observed 
with increasing YpdA concentration, 
resulting in an R2 value of 0.93 (Graph 1). 
Comparison of initial velocity with increasing 
Figure 4- SDS PAGE analysis of impure 
BrxB Bs Ni affinity chromatography 
fractions from transformed BL-21 cells: 
Lane 1 includes a protein ladder. Lanes 2-4 
include purified fractions 8-10. Lane 5 includes 
fraction 12, lane 6 fraction 14, and lane 7 
fraction 16. Lanes 8-10 include fractions 17-
19.  
1  2 3  4  5  6 7  8  9 10  1  2   3  4  5  6   7  8  9 10 
Figure 5- SDS PAGE analysis of pure BrxA 
Sa Ni affinity chromatography fractions 
from transformed BL-21 cells: Lane 10 
includes a protein ladder. Lane 1 includes 
purified fraction 8, lane 2 fraction 10, lane 3 
fraction 12, lane 4 fraction 14, lane 5 fraction 
16, lane 6 fraction 18, lane 7 fraction 20, lane 
8 fraction 22, and lane 9 fraction 25.  
Figure 6: Assay validation of YpdA with 40µM BSSB 
BSSB concentration suggests the possibility 
of typical enzyme-substrate hyperbolic 
behavior (Graph 2), however, the assay was 
not completed under steady state conditions 
due to a very high enzyme concentration. 
These results suggest that YpdA may 
function as a reductase of BSSB at a very 
slow catalytic rate, but the role and 
inclusion of YpdA in the bacillithiol 
pathway remains questionable. Based on 
these results, YpdA may perform this 
reaction in the cell, however, the 
intracellular enzyme concentration would 
have to be very high. It is also possible that the purification and expression process used to 
obtain YpdA resulted in an enzyme with lower activity than would be observed intracellularly, or 
other factors could be missing from the experimental design. Further investigation under steady 
state conditions is required to accurately assess YpdA activity.   
Structure of BrxA from S. aureus  
Graph 1: Analysis of initial YpdA activity 
with increasing enzyme concentration.  
Graph 2: Analysis of initial YpdA activity with 
increasing BSSB concentration.  
A data set was collected from BrxA S. aureus with BSSB bound in the active site. A 1.37 
Å structure was solved and the asymmetric unit was shown to contain one polypeptide. 
Crystallization and 
refinement statistics are 
displayed in Table 1. 
Ramachandran statistics are 
good, indicating that 97.5 % 
of residues fall within 
favored regions (Table 1). 
We presume the formation 
of a biological homodimer 
is likely in BrxA S. aureus (Figure 7), as is observed in other 
thioredoxins, and as predicted by PDBePISA (Krissinel and 
Henrick 2007). The active site region is present near the protein’s surface, allowing for ease of 
interaction between BrxA and other proteins 
during bacillithiol transfer.   
 
Figure 7: Cartoon diagram 
of presumed biological 
dimer of BrxA S. aureus 
colored by chain.  
Data collection statistics 
Space Group P41212 
Unit cell dimensions (Å) a = b = 85.7, c = 42.1 
Resolution Limits (Å) 42.9–1.37(1.47–1.37)a 
Number of Independent 
Reflections 
23743 (1188) 
Completeness (%) 94.7 (64.8) 
Redundancy  23.6 (15.5) 
Avg (I / σ(I)) 27.7 (1.3) 
Rmerge 0.053 (1.683) 
Rpim  0.015 (0.595) 
CC1/2 .999 (.588) 
 
Refinement statistics 
Roverall (%) 19.9 
Rwork (%)  19.9 
Rfree (%) 21.5 
No. Protein Atoms 1107 
No. Hetero-Atoms 107b 
Average B values 
Protein Atoms (Å2) 26.0 
Ligand Atoms (Å2) 34.3 
Solvent (Å2) 30.3 
Weighted root-mean-square deviations from ideality 
Bond Lengths (Å) 0.013 
Bond Angles (deg) 1.859 
General Planes (Å) 0.009 
Ramachandran statistics 
Favored (%) 97.5 
Allowed (%) 1.67 
Outliers (%) 0.83 
 
Table 1: Crystallization and 
refinement statistics from BrxA S. 
aureus.  
aValues in parentheses are for the highest 
resolution bin. bHeteroatoms include 77 water 
molecules, 1 BSSB, and 1 PO4- molecule. 
Active site 
The BrxA S. aureus active site contains a well-defined bacillithiol covalently bound to 
Cys54. This structure is the 
first to reveal that the N-
terminal cysteine in the CXC 
catalytic motif is responsible 
for bacillithiol binding (Figure 
8). Arg121 lies in near 
proximity to the bound 
substrate and likely functions 
in stabilization of the thiolate 
formed during the bacillithiol 
transferase reaction.  
Comparison with BrxA B. subtilis 
Comparison of the structure of 
BrxA S. aureus presented here, with 
that of previously characterized apo 
BrxA B. subtilis, reveals a similar 
monomeric conformation, with only 
slight differences (Figure 9). The 
binding of bacillithiol in the active site 
by Cys54 observed in BrxA S. aureus 
reveals that Cys53 in BrxA B. subtilis 
Cys54 
Arg121 
Figure 8: Diagram of BrxA S. aureus active site with a 
bacillithiol bound. Residues involved in substrate 
interaction are labeled.  
Figure 9: Cartoon diagram displaying the 
overlay of monomers from BrxA S. aureus 
(green) with BrxA B. subtilis (purple). 
is likely responsible for substrate 
binding in a similar manner. The 
residues are located near the same 
position in the active site, at the N-
terminal end of the CXC catalytic 
motif. Arg121 is also shown to be 
present in both enzymes, likely 
functioning in thiolate stabilization 
(Figure 10). Overall, these results suggest a 
high degree of similarity in BrxA between 
these organisms. 
Conclusion 
 The X-ray crystallographic structure of BrxA presented here is the first ever X-ray 
crystallographic structure of a Brx enzyme bound in a BSS-Brx mixed disulfide, and the first 
structure of BrxA from S. aureus. Elucidation of this structure provides insight into the exact 
manner of bacillithiol binding, and the mechanism of bacilliredoxin activity. Novel discoveries 
into the BSH regeneration pathway in pathogenic firmicutes such as S. aureus and B. anthracis 
can aid in combatting bacterial resistance to antibiotics such as fosfomycin, as well as providing 
a potential for novel drug therapies.  
  
                                                                                                                
 
 
Figure 10: Overlay of active site from BrxA S. 
aureus (green) with BrxA B. subtilis (purple). 
Residues involved in substrate interaction are 
labeled. 
Cys54 
Cys53 
Arg121 
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ABSTRACT 
A unique O-antigen known as the A-band is present in the lipopolysaccharide of Pseudomonas 
aeruginosa and consists of the deoxy sugar D-rhamnose. GDP-linked  
D-rhamnose production involves a two-enzyme pathway, including the short-chain 
dehydrogenase/reductase GDP-4-keto-6-deoxymannose-4-reductase, also known as RMD. Here 
we describe the first ever X-ray crystallographic structure of RMD from P. aeruginosa, which is 
also the first RMD structure that displays a well-ordered NADPH cofactor. Elucidation of this 
structure provides insight into the catalytic mechanism of RMD and the D-rhamnose biosynthetic 
pathway.  
 
Keywords: Lipopolysaccharide, Pseudomonas, X-ray crystallography, O-antigen, short-chain 
dehydrogenase/reductase 
 INTRODUCTION  
Gram-negative bacteria display on their surface a membrane-associated 
lipopolysaccharide (LPS), which functions in stabilization, defense from antimicrobials, 
communication, and participation in host immune response.1, 2 The distal portion of the LPS 
contains a repeating sugar structure known as the O-antigen. Compositional variation among O-
antigens can contribute to a pathogen’s virulence. This effect is displayed in the common 
nosocomial pathogen Pseudomonas aeruginosa, in which an O-antigen termed A-band is 
composed of the deoxy sugar D-rhamnose.3 O-antigen biosynthesis utilizes nucleotide-linked 
sugars, and in P. aeruginosa, D-rhamnose biosynthesis begins with GDP-D-mannose. Via GDP-
mannose-4,6-dehydratase (GMD), GDP-mannose undergoes dehydration to produce GDP-4-
keto-6-deoxymannose (Scheme S1).4 The keto group is then reduced in a stereospecific manner 
by GDP-4-keto-6-deoxymannose-4-reductase (RMD) to produce GDP-D-rhamnose. RMD 
utilizes either NADPH or NADH with no significant preference.5 
GMD has been well-characterized. An X-ray crystallographic structure was determined 
for RMD from Aneurinibacillus thermoaerophilus (AtRMD).3 However, that structure contains a 
partially disordered NADPH cofactor that lacks the redox-active nicotinamide ring. Here we 
describe the 1.9 Å resolution crystal structure of NADPH-bound RMD from P. aeruginosa 
(PaRMD), the first ever RMD structure from this organism. The nicotinamide ring of the 
NADPH is clearly defined and provides insight into the catalytic mechanism of RMD.  
 
2. MATERIALS AND METHODS 
PaRMD was expressed recombinantly in Escherichia coli and purified by nickel affinity 
chromatography. Crystals of RMD with an N-terminal hexahistidine tag were grown via vapor 
diffusion. The crystals were frozen in liquid nitrogen and X-ray data were collected at the Life 
Sciences Collaborative Access Team at Argonne National Laboratory. The structure was solved 
via molecular replacement using AtRMD (PDB ID 2PK3) as the search model.3 Data collection 
and refinement statistics are displayed in Table 1. Additional experimental details can be found 
in the Supporting Information. 
 
3. RESULTS AND DISCUSSION 
3.1 Overall structure 
The RMD crystals from this experiment contained four polypeptide chains in the 
asymmetric unit. Ramachandran statistics determined from the PDB Validation Report indicate 
97.9 % of residues are present in favored regions, with no outliers (Table 1). The A and B chains 
are well ordered overall, but the C and D chains contain several surface loops that are partially 
disordered. Nonetheless, we were able to model most of each polypeptide chain, with the 
exception of the termini and a chain break in a loop roughly between Gln154 and Gln164 in all 
four chains. This loop is located at the surface of the protein and is away from the active site 
region. The RMD monomer contains a Rossman fold core as expected in short-chain 
dehydrogenase/reductase (SDR) family enzymes (Figure 1A, 1B and S1). Examination of the 
unit cell contents and analysis via PDBePISA6 support the formation of the dimer commonly 
seen among SDR enzymes in which a four-helix bundle forms an interface between chains A and 
B (Figure S1B, Supporting Information). Chains C and D form a second copy of this biological 
dimer.  
 3.2 Active site 
RMD binds NAD(P)H in the N-terminal domain and GDP-4-keto-6-deoxymannose in the 
C-terminal domain. Electron density corresponding to NADPH was apparent in the active site in 
all four chains (Figure S2A). Given that the electron density map is strongest for the ligand in 
chain B, the remainder of this analysis will refer to it. Several side chain and main chain groups 
interact with NADPH (Figure 1C). Many of these interactions are identical to those found in 
AtRMD, including stabilization of the NADPH phosphoryl groups via interactions with the δ+ 
end of the α1 helix. The nicotinamide ring in our structure is clearly ordered, and its amide group 
forms a hydrogen bond with the side chain of Gln166. The catalytic triad residues Ser105, 
Tyr131, and Lys135 are all situated near the B-face of the nicotinamide ring. Ser105 makes no 
interactions with NADPH, but Tyr131 and Lys135 hydrogen bond to the NADPH ribose 
hydroxyl groups. Several peaks in the Fo - Fc map were present within the GDP-4-keto-6-
deoxymannose binding site that belonged to a low occupancy NADPH molecule bound in a non-
productive manner. The density was strong enough to model this additional NADPH into chain 
D and pyrophosphate into Chain B, but we left the density unmodeled in chains A and C. 
 
3.3 Mechanism 
The AtRMD structure contains GDP-mannose bound within the GDP-4-keto-6-
deoxymannose binding site.3 Therefore, the superposition of the AtRMD and PaRMD structures 
provides a good model for the product-bound state of the enzyme (Figure 1D and S3). The 
superposition places the 4-carbon of GDP-mannose near the 4-carbon of the nicotinamide ring 
and the 4-hydroxyl group of GDP-mannose near Ser105 and Tyr131. This arrangement of groups 
supports a mechanism in which Tyr131 protonates the keto oxygen while the hydride is 
transferred from NAD(P)H (Scheme S2).7 Ser105 serves to stabilize the forming hydroxyl group, 
whereas Lys135 lowers the pKa of Tyr131 and participates in a proton relay assisted by the 2-
hydroxyl group of the ribose.  
 The structure of RMD presented here provides insight into the biosynthesis of D-
rhamnose, a deoxy sugar that forms a critical component within the LPS of the pathogenic 
bacterium P. aeruginosa. Furthermore, a thorough understanding of deoxysugar biosynthesis 
pathways can aid in the production of novel sugars.8 Such sugars can be utilized in 
glycodiversification processes such as attachment to macrolide antibiotic scaffolds to make novel 
therapeutic compounds.9 
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Table 1: X-ray Data Collection and Refinement Statistics 
 RMD 
(6X3B) 
Data collection statistics 
Space Group P21 
Unit cell dimensions (Å) a = 97.7, b =54.1, 
 c =137.9, β = 107.7° 
Resolution Limits (Å) 34.03–1.91(1.94–1.91)a 
Number of Independent 
Reflections 
105890 (5178) 
Completeness (%) 99.1 (98.5) 
Redundancy 5.0 (5.0) 
Avg (I / σ(I)) 8.5 (1.6) 
Rmerge 0.090 (0.813) 
Rpim 0.070 (0.622) 
CC1/2 0.997 (0.666) 
Refinement statistics 
Roverall (%) 18.9 
Rwork (%)  18.7 
Rfree (%) 22.4 
No. Protein Atoms 9141b 
No. Hetero-Atoms 778c 
Average B values 
Protein Atoms (Å2) 35.3 
Ligand Atoms (Å2) 35.5 
Solvent (Å2) 35.6 
Weighted root-mean-square deviations from ideality 
Bond Lengths (Å) 0.007  
Bond Angles (deg) 0.85 
General Planes (Å) 0.005 
Ramachandran statistics 
Favored (%) 97.9 
Allowed (%) 2.1 
Outliers (%) 0 
aValues in parentheses are for the highest resolution bin. 
bFour polypeptides (two biological dimers) are present in the asymmetric unit. 
cHeteroatoms include 525 water molecules, five NADPH molecules, one pyrophosphate ion, and one nitrate ion. 
 
 
  
FIGURE LEGENDS 
Figure 1. The structure of RMD. (A) Cartoon diagram of the RMD monomer with NADPH 
shown in spheres. The binding site for the substrate GDP-4-keto-6-deoxymannose in the C-
terminal domain is indicated. All macromolecular graphics were generated in PyMOL.10 (B) 
Amino acid sequence of RMD. The secondary structural elements labelled within the RMD 
structure are shown in blue above the sequence. The numbers in black below the sequence 
indicate the residue number at the beginning of an element. (C) Close-up view of the RMD 
active site. Polar interactions within 3.2 Å of the NADPH are shown with dashed lines. The 
adenine base is indicated with an “A” and the nicotinamide group is indicated with an “N” for 
clarity. (D) Superposition of RMD structures. The PaRMD structure is shown with green 
carbons, whereas the AtRMD structure is shown with tan carbons and labels with asterisks. 
Carbon #4 in both NADPH and GDP-mannose are labelled. The dashed lines indicate hydrogen 
bonding interactions relevant to the catalytic mechanism.  
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SUPPORTING INFORMATION 
GDP-D-rhamnose biosynthesis pathway, additional materials and methods, stereo figures, and 
RMD catalytic mechanism. 
 
